McCulloch Kevin
Reporting owner on Forms 3, 4 and 5, CIK 2031695.
McCulloch Kevin reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-10-02.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. CIK 1867096 | officer (See Remarks) | 2 | 2026-10-02 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Xeris Biopharma Holdings, I… Common Stock | 2026-10-01 | S sold | -15,000 | $9.408 | 1,599,208 | Form 4 |
| Xeris Biopharma Holdings, I… Common Stock, holding | 25,000 | Form 4 | ||||
| Xeris Biopharma Holdings, I… Common Stock | 2026-09-28 | S sold | -25,000 | $10 | 1,614,208 | Form 4 |
| Xeris Biopharma Holdings, I… Common Stock, holding | 25,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001867096-26-000085 | Xeris Biopharma Holdings, Inc. | 2026-10-02 | ||
| Form 4 0001867096-26-000078 | Xeris Biopharma Holdings, Inc. | 2026-09-29 |